{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:46:51Z","timestamp":1768700811449,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["Grant No. ZR2020MH339"],"award-info":[{"award-number":["Grant No. ZR2020MH339"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["Grant No. ZR2021MH133"],"award-info":[{"award-number":["Grant No. ZR2021MH133"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["Grant No. 2018WS470"],"award-info":[{"award-number":["Grant No. 2018WS470"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["Grant No.2019-0746"],"award-info":[{"award-number":["Grant No.2019-0746"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10067-022-06220-0","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T11:03:48Z","timestamp":1653908628000},"page":"2929-2938","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness of thalidomide for ankylosing spondylitis: a meta-analysis of randomized controlled trials in China"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8330-2949","authenticated-orcid":false,"given":"Dongsen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3684-2704","authenticated-orcid":false,"given":"Xuemei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9130-906X","authenticated-orcid":false,"given":"Xuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7000-9412","authenticated-orcid":false,"given":"Chunying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4965-207X","authenticated-orcid":false,"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8878-8100","authenticated-orcid":false,"given":"Yuqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5686-3863","authenticated-orcid":false,"given":"Guoyong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8746-8743","authenticated-orcid":false,"given":"Qingjian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"issue":"5","key":"6220_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.semarthrit.2014.10.009","volume":"44","author":"A Boonen","year":"2015","unstructured":"Boonen A, Sieper J, D\u00e9sir\u00e9e V, Dougados M, Bukowski JF, Valluri S, Vlahos B, Kotak S (2015) The burden of non-radiographic axial spondyloarthritis. Semin Arthritis Rheum 44(5):556\u2013562. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.10.009","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"6220_CR2","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/art.1780360414","volume":"34","author":"M Dougados","year":"1991","unstructured":"Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34(10):1218\u20131227. https:\/\/doi.org\/10.1002\/art.1780360414","journal-title":"Arthritis Rheum"},{"issue":"4","key":"6220_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/BOR.0b013e32834640a9","volume":"23","author":"S Zhang","year":"2011","unstructured":"Zhang S, Li Y, Deng X, Huang F (2011) Similarities and differences between spondyloarthritis in Asia and other parts of the world. Curr Opin Rheumatol 23(4):334. https:\/\/doi.org\/10.1097\/BOR.0b013e32834640a9","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"6220_CR4","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-012-2571-5","volume":"33","author":"X Deng","year":"2013","unstructured":"Deng X, Zhang J, Zhang J, Huang F (2013) Thalidomide reduces recurrence of ankylosing spondylitis in patients following discontinuation of etanercept. Rheumatol Int 33(6):1409\u20131413. https:\/\/doi.org\/10.1007\/s00296-012-2571-5","journal-title":"Rheumatol Int"},{"issue":"9","key":"6220_CR5","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00296-013-2772-6","volume":"33","author":"MA Machado","year":"2013","unstructured":"Machado MA, Barbosa MM, Almeida AM, de Ara\u00fajo VE, Kakehasi AM, Andrade EI, Cherchiglia ML, AcurcioFde A (2013) Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis. Rheumatol Int 33(9):2199\u20132213. https:\/\/doi.org\/10.1007\/s00296-013-2772-6","journal-title":"Rheumatol Int"},{"issue":"4","key":"6220_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/jcph.1348","volume":"59","author":"J Wro\u0144ski","year":"2018","unstructured":"Wro\u0144ski J, Fiedor P (2018) The safety profile of tumor necrosis factor inhibitors in ankylosing spondylitis: are TNF inhibitors safer than we thought? Clin Immunol 59(4):445\u2013462. https:\/\/doi.org\/10.1002\/jcph.1348","journal-title":"Clin Immunol"},{"issue":"2","key":"6220_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.clim.2013.03.004","volume":"147","author":"T Kawai","year":"2013","unstructured":"Kawai T, Watanabe N, Yokoyama M, Arai K, Oana S, Harayama S, Yasui K, Oh-Ishi T, Onodera M (2013) Thalidomide attenuates excessive inflammation without interrupting lipopolysaccharide-driven inflammatory cytokine production in chronic granulomatous disease. Clin Immunol 147(2):122\u2013128. https:\/\/doi.org\/10.1016\/j.clim.2013.03.004","journal-title":"Clin Immunol"},{"issue":"2","key":"6220_CR8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/187221310791163026","volume":"4","author":"JB De Sanctis","year":"2010","unstructured":"De Sanctis JB, Mijares M, Su\u00e1rez A, Compagnone R, Garmendia J, Moreno D, Salazar-Bookaman M (2010) Pharmacological properties of thalidomide and its analogues. Recent Pat Inflamm Allergy Drug Discov 4(2):144\u2013148. https:\/\/doi.org\/10.2174\/187221310791163026","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"6220_CR9","doi-asserted-by":"publisher","unstructured":"Gui Y, Shi l, Xun W, Li Z, Han D, Li T (2017) Efficacy and safety of thalidomide in the treatment of ankylosing spondylitis (in Chinese). Mod Diagn Treat 28(18):3382\u20133384. https:\/\/doi.org\/10.3969\/j.issn.1001-8174.2017.18.029","DOI":"10.3969\/j.issn.1001-8174.2017.18.029"},{"issue":"26","key":"6220_CR10","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.16281\/j.cnki.jocml.2017.26.029","volume":"4","author":"J Zhang","year":"2017","unstructured":"Zhang J (2017) Clinical evaluation of thalidomide in the treatment of ankylosing spondylitis (in Chinese). J Clin Med 4(26):4995\u20134996. https:\/\/doi.org\/10.16281\/j.cnki.jocml.2017.26.029","journal-title":"J Clin Med"},{"issue":"17","key":"6220_CR11","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.19435\/j.1672-1721.2020.17.021","volume":"24","author":"D Xie","year":"2020","unstructured":"Xie D (2020) Effect of thalidomide on patients with ankylosing spondylitis (in Chinese). Med Forum 24(17):2405\u20132406. https:\/\/doi.org\/10.19435\/j.1672-1721.2020.17.021","journal-title":"Med Forum"},{"issue":"11","key":"6220_CR12","first-page":"90","volume":"6","author":"K Luo","year":"2019","unstructured":"Luo K (2019) Analysis of curative effect of thalidomide on ankylosing spondylitis (in Chinese). Healthful Friend 6(11):90\u201391","journal-title":"Healthful Friend"},{"issue":"9","key":"6220_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3969\/j.issn.1004-437X.2015.09.019","volume":"24","author":"J Tian","year":"2015","unstructured":"Tian J (2015) Clinical effect of thalidomide on ankylosing spondylitis (in Chinese). Henan Med Res 24(9):43\u201345. https:\/\/doi.org\/10.3969\/j.issn.1004-437X.2015.09.019","journal-title":"Henan Med Res"},{"issue":"19","key":"6220_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3969\/j.issn.1674-9308.2018.19.068","volume":"10","author":"H Xiang","year":"2018","unstructured":"Xiang H, Heng M (2018) Thalidomide combined with recombinant human tumor necrosis factor receptor antibody fusion protein for injection in the treatment of refractory ankylosing spondylitis (in Chinese). China Contin Med Educ 10(19):127\u2013128. https:\/\/doi.org\/10.3969\/j.issn.1674-9308.2018.19.068","journal-title":"China Contin Med Educ"},{"issue":"7","key":"6220_CR15","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3969\/j.issn.1674-4659.2019.07.0957","volume":"26","author":"Y Wei","year":"2019","unstructured":"Wei Y, Xia N, Zhang W, Ren Z, Huang J, Zhu L, Zhang Z, Yang L (2019) Influence of thalidomide combined with sulfasalazine on inflammatory response in patients with ankylosing spondylitis (in Chinese). Clin Med Eng 26(7):957\u2013958. https:\/\/doi.org\/10.3969\/j.issn.1674-4659.2019.07.0957","journal-title":"Clin Med Eng"},{"issue":"9","key":"6220_CR16","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3969\/j.issn.1004-437X.2020.09.052","volume":"29","author":"F Zhao","year":"2020","unstructured":"Zhao F, Liu S (2020) Effect of sulfasalazine combined with thalidomide in the treatment of ankylosing spondylitis (in Chinese). Henan Med Res 29(9):1648\u20131649. https:\/\/doi.org\/10.3969\/j.issn.1004-437X.2020.09.052","journal-title":"Henan Med Res"},{"issue":"4","key":"6220_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.13214\/j.cnki.cjotadm.2019.04.036","volume":"27","author":"Y Gao","year":"2019","unstructured":"Gao Y (2019) Clinical evaluation of thalidomide combined with sulfasyridine for ankylosing spondylitis (in Chinese). Chin J Trauma Disabil Med 27(4):54\u201355. https:\/\/doi.org\/10.13214\/j.cnki.cjotadm.2019.04.036","journal-title":"Chin J Trauma Disabil Med"},{"issue":"1","key":"6220_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3969\/j.issn.1004-4337.2016.01.040","volume":"29","author":"J Gan","year":"2016","unstructured":"Gan J (2016) Clinical observation of thalidomide combined with sulfasyridine in the treatment of ankylosing spondylitis (in Chinese). J Math Med 29(1):75\u201376. https:\/\/doi.org\/10.3969\/j.issn.1004-4337.2016.01.040","journal-title":"J Math Med"},{"issue":"4","key":"6220_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3969\/j.issn.1004-437X.2018.04.043","volume":"27","author":"T Hou","year":"2018","unstructured":"Hou T (2018) The effectiveness analysis of Thalidomide in the Treatment of Ankylosing Spondylitis (in Chinese). Henan Med Res 27(4):662\u2013663. https:\/\/doi.org\/10.3969\/j.issn.1004-437X.2018.04.043","journal-title":"Henan Med Res"},{"issue":"20","key":"6220_CR20","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3969\/j.issn.1002-1256.2017.20.026","volume":"38","author":"X Zeng","year":"2017","unstructured":"Zeng X (2017) Long-term efficacy and safety analysis of thalidomide in the treatment of ankylosing spondylitis (in Chinese). J Qiqihar Univ Med 38(20):2412\u20132414. https:\/\/doi.org\/10.3969\/j.issn.1002-1256.2017.20.026","journal-title":"J Qiqihar Univ Med"},{"issue":"23","key":"6220_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14163\/j.cnki.11-5547\/r.2016.23.001","volume":"11","author":"G Li","year":"2016","unstructured":"Li G, Yuan Y (2016) Analysis of curative effect by thalidomide in the treatment of ankylosing spondylitis (in Chinese). China Prac Med 11(23):1\u20133. https:\/\/doi.org\/10.14163\/j.cnki.11-5547\/r.2016.23.001","journal-title":"China Prac Med"},{"issue":"30","key":"6220_CR22","first-page":"96","volume":"6","author":"W Han","year":"2016","unstructured":"Han W (2016) Long-term efficacy and safety of thalidomide in the treatment of ankylosing spondylitis (in Chinese). Yiyao Qianyan 6(30):96\u201397","journal-title":"Yiyao Qianyan"},{"issue":"10","key":"6220_CR23","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.7501\/j.issn.1674-6376.2017.10.024","volume":"40","author":"X Sun","year":"2017","unstructured":"Sun X, Liu L, Cao J, Zheng S, Tang J, Medicine G (2017) The activity and functional activity effect of sulfasalazine enteric coated tablets combined with thalidomide in the treatment of ankylosing spondylitis patients (in Chinese). Drug Eval Res 40(10):1477\u20131480. https:\/\/doi.org\/10.7501\/j.issn.1674-6376.2017.10.024","journal-title":"Drug Eval Res"},{"key":"6220_CR24","doi-asserted-by":"publisher","unstructured":"Yao YK, Liu X (2020) A meta-analysis of therapeutic effect of thalidomide on ankylosing spondylitis. J Adv Med Sci 3(3):2591\u20137617. https:\/\/doi.org\/10.30564\/jams.v3i3.2271","DOI":"10.30564\/jams.v3i3.2271"},{"key":"6220_CR25","unstructured":"Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2021) Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). http:\/\/www.trainingcochraneorg\/handbook, Accessed 2 January, 2022"},{"issue":"1","key":"6220_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13643-017-0663-8","volume":"6","author":"MJ Page","year":"2017","unstructured":"Page MJ, Moher D (2017) Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review. Syst Rev 6(1):263. https:\/\/doi.org\/10.1186\/s13643-017-0663-8","journal-title":"Syst Rev"},{"issue":"1","key":"6220_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"ARMR Jadad","year":"1996","unstructured":"Jadad ARMR, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1\u201312. https:\/\/doi.org\/10.1016\/0197-2456(95)00134-4","journal-title":"Control Clin Trials"},{"issue":"1","key":"6220_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3969\/j.issn.2095-7629.2019.01.105","volume":"17","author":"J Ran","year":"2018","unstructured":"Ran J (2018) Observation of therapeutic effects of thalidomide in the treatment of ankylosing spondylitis (in Chinese). Contemp Med Forum 17(1):137\u2013138. https:\/\/doi.org\/10.3969\/j.issn.2095-7629.2019.01.105","journal-title":"Contemp Med Forum"},{"issue":"24","key":"6220_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3969\/j.issn.1674-9316.2016.24.061","volume":"7","author":"K Zhu","year":"2016","unstructured":"Zhu K, Liu F, Li Y (2016) Analysis of curative effect by thalidomide and sulfasalazine in the treatment of ankylosing spondylitis (in Chinese). China Health Stand Manag 7(24):106\u2013108. https:\/\/doi.org\/10.3969\/j.issn.1674-9316.2016.24.061","journal-title":"China Health Stand Manag"},{"issue":"35","key":"6220_CR30","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.3969\/j.issn.2095-4344.1955","volume":"23","author":"J Zhou","year":"2019","unstructured":"Zhou J, Fu L, Zhou Z, Li Q (2019) One-year evaluation of recombinant human tumor necrosis factor-alpha receptor II decrement combined with thalidomide increment in the treatment of active ankylosing spondylitis (in Chinese). Chin J Tissue Eng Res 23(35):5664\u20135669. https:\/\/doi.org\/10.3969\/j.issn.2095-4344.1955","journal-title":"Chin J Tissue Eng Res"},{"issue":"15","key":"6220_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3969\/j.issn.1674-3296.2009.15.005","volume":"2","author":"J Wu","year":"2009","unstructured":"Wu J (2009) Clinical observation of treatment of 65 cases of ankylosing spondylitis with thalidomide therapy (in Chinese). Chin J Clin Ration Drug Use 2(15):11\u201312. https:\/\/doi.org\/10.3969\/j.issn.1674-3296.2009.15.005","journal-title":"Chin J Clin Ration Drug Use"},{"key":"6220_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/OARRR.S130176","volume":"10","author":"CF Rabelo","year":"2018","unstructured":"Rabelo CF, Baptista TSA, Petersen LE, Bauer ME, Staub HL (2018) Serum IL-6 correlates with axial mobility index (Bath Ankylosing Spondylitis Metrology Index) in Brazilian patients with ankylosing spondylitis. Open Access Rheumatol 10:21\u201325. https:\/\/doi.org\/10.2147\/OARRR.S130176","journal-title":"Open Access Rheumatol"},{"issue":"4","key":"6220_CR33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/art.1780380407","volume":"38","author":"J Braun","year":"2010","unstructured":"Braun J, Bollow M, Neure L, Seipelt E, Sieper J (2010) Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38(4):499\u2013505. https:\/\/doi.org\/10.1002\/art.1780380407","journal-title":"Arthritis Rheum"},{"issue":"6","key":"6220_CR34","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/art.37937","volume":"65","author":"H Appel","year":"2013","unstructured":"Appel H, Maier R, Bleil J, Hempfing A, Loddenkemper C, Schlichting U, Syrbe U, Sieper J (2013) In situ analysis of interleukin-23- and interleukin-12-positive cells in the spine of patients with ankylosing spondylitis. Arthritis Rheum 65(6):1522\u20131529. https:\/\/doi.org\/10.1002\/art.37937","journal-title":"Arthritis Rheum"},{"issue":"10","key":"6220_CR35","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.4049\/jimmunol.159.10.5157","volume":"159","author":"D Moller","year":"1997","unstructured":"Moller D (1997) Inhibition of IL-12 production by thalidomide. J Immunol 159(10):5157\u20135161","journal-title":"J Immunol"},{"issue":"6","key":"6220_CR36","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","volume":"177","author":"AL Moreira","year":"1993","unstructured":"Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G (1993) Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 177(6):1675\u20131680. https:\/\/doi.org\/10.1084\/jem.177.6.1675","journal-title":"J Exp Med"},{"issue":"3","key":"6220_CR37","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1084\/jem.173.3.699","volume":"173","author":"EP Sampaio","year":"1991","unstructured":"Sampaio EP, Sarno EN, Galilly R, Cohn ZA, Kaplan G (1991) Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 173(3):699\u2013703. https:\/\/doi.org\/10.1084\/jem.173.3.699","journal-title":"J Exp Med"},{"issue":"13","key":"6220_CR38","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.2174\/156802612801784443","volume":"12","author":"S Majumder","year":"2012","unstructured":"Majumder S, Sreedhara SR, Banerjee S, Chatterjee S (2012) TNF \u03b1 signaling beholds thalidomide saga: a review of mechanistic role of TNF-\u03b1 signaling under thalidomide. Curr Top Med Chem 12(13):1456\u20131467. https:\/\/doi.org\/10.2174\/156802612801784443","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"6220_CR39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/art.1780260210","volume":"26","author":"S Carette","year":"2014","unstructured":"Carette S, Graham D, Little H, Rubenstein J, Rosen P (2014) The natural disease course of ankylosing spondylitis. Arthritis Rheum 26(2):186\u2013190. https:\/\/doi.org\/10.1002\/art.1780260210","journal-title":"Arthritis Rheum"},{"key":"6220_CR40","doi-asserted-by":"publisher","first-page":"814","DOI":"10.4103\/1673-5374.156988","volume":"5","author":"H Xue","year":"2015","unstructured":"Xue H, Fu W, Cui H, Yang L, Zhang N, Zhao L (2015) High-dose thalidomide increases the risk of peripheral neuropathy in the treatment of ankylosing spondylitis. Neural Regen Res 5:814\u2013818. https:\/\/doi.org\/10.4103\/1673-5374.156988","journal-title":"Neural Regen Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06220-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06220-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06220-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T18:39:59Z","timestamp":1675708799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06220-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["6220"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06220-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,30]]},"assertion":[{"value":"29 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}